Search
Menu Menu

There may be no link between serotonin levels and depression

A major review of 17 existing studies has uncovered ‘no convincing evidence’ depression is caused by a chemical imbalance.

According to new research, depression may not be caused by low levels of serotonin.

The finding comes after University College London conducted a major review of 17 existing studies and realised there was ‘no convincing evidence’ linking the mental health condition with a chemical imbalance.

This has prompted many to question the efficacy of medications that target brain-signalling molecules, however not everyone is convinced by the recently published verdict and experts are urging people not to stop taking their antidepressants in light of the news they’re no longer a ‘cure.’

The original serotonin hypothesis – which dates back to the 1960s – states that a chemical imbalance in the brain, including low levels of serotonin (also known as 5-hydroxytryptamine or 5-HT), is what leads to depression.

Yet the current assumption is that various biological, psychological, and environmental factors are primarily to blame.

For this reason, scientists believe that serotonin reuptake inhibitors (SSRIs), as they’re also called, are not working in some circumstances.

Should the serotonin theory of depression be abandoned? - Hospital Healthcare Europe

‘It is always difficult to prove a negative, but I think we can safely say that after a vast amount of research conducted over several decades, there is no convincing evidence that depression is caused by serotonin abnormalities, particularly by lower levels or reduced activity of serotonin,’ says consultant psychiatrist, Joanna Moncrieff.

The paper’s lead author, it was Moncrieff who directed an ‘umbrella analysis’ of almost 20 systematic studies involving tens of thousands of people to uncover little substantiation that depressed people had abnormal serotonin activity compared with non-depressed people.

As she explains, the popularity of the ‘chemical imbalance’ theory that’s widely put forward by professionals has coincided with a huge surge in the use of antidepressants (at present, 8.3 million people in the UK alone are taking them following a six per cent increase last year).

Consequently, thousands are suffering from various side-effects and the severe withdrawal that can occur when people try to come off them, though prescription rates continue to rise.

In addition,, if antidepressants exert their effects as placebos, or by numbing emotions, then it is not clear that they do more good than harm.

In Moncrieff’s opinion – supported by her colleagues – this situation has been driven partly by the incorrect notion that depression has anything to do with serotonin levels.

Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature | PLOS Medicine

‘It is high time to inform the public that this belief is not grounded in science,’ she adds.

‘We do not understand what antidepressants are doing to the brain exactly and giving people this sort of misinformation prevents them from making an informed decision about whether to take antidepressants or not.’

On the other hand, it’s essential to note that antidepressants will complexly vary in effectiveness for different people, which is why those in opposition to Moncrieff’s claims stress the value of regularly reviewed patient care based on the individual’s needs.

This, as well as further research into promising treatments for depression such as psychedelic therapy, for example, is what they deem of utmost priority before anyone starts thinking they ought to throw their SSRIs away.

‘It is important that people with severe depression are not discouraged from receiving appropriate treatments, which can make a huge difference to them and those around them,’ says a spokesperson for the Royal College of Psychiatrists, who fears that the paper will simply add to public confusion regarding what depression is and what it isn’t.

‘We would not recommend for anyone to stop taking their antidepressants based on this review and encourage anyone with concerns about their medication to contact their GP.’

 

Thred Newsletter!

Sign up to our planet-positive newsletter

Accessibility